|
The Colorectal Cancer Tissue Bank
Background
The colorectal cancer tissue bank was established in 1999. The tissue
bank embodies an infrastructure for collection of neoplastic and non-neoplastic
colorectal tissues and their associated clinicopathological data. Physically,
the bank is situated at the CMCC, Aarhus University Hospital, Skejby,
Brendstrupgaardsvej 21, 8200 Aarhus N, Denmark. The biobank is maintained
in a collaborative effort by the Colorectal Cancer Group at the Department
of Molecular Medicine and following surgical departments:
Aim
The main purpose of the colorectal cancer tissue bank is to provide a
framework for research into the molecular and cell biological aspects
of colorectal cancer. Over the past years it has become evident that large
well documented tissue banks are often the key to successful translation
of basic research into clinical practice.
Ethics
Neoplastic tissue accepted into the colorectal cancer tissue bank originates
from the healthcare activities at the hospitals associated. Tissue and
clinical information is collected in accordance with standard operating
procedures which guarantee ethical conduct.
These can be summarized as follows:
Patients are informed about the aim and aspects of the tissue bank both
orally and in writing. Only if the patient signs an informed consent form
will the patient’s tissue be accepted into the tissue bank. Patients
can always withdraw their consent and their tissue will then be destroyed.
Under no circumstances may the diagnosis of a patient be compromised by
collection to the tissue bank.
The patients accepted into the tissue bank are registered anonymously
in a central database. Each patient is assigned a database identification
code. This code is used to link the patient’s samples and clinical
information. The research scientist using the tissue bank will not have
access to the identity of the patients.
Information to link the database identification code with the personal
identity of the patient (name, surname, and the Danish civil registry
number) is saved in a separate “key” database. Only the clinicians
entering the patient data into the database and the database administrator
can access this “key” database.
In certain research projects, access to further data concerning the clinical
history of the patient can be necessary. In such circumstances it can
be requested that the database manager seeks to collect this additional
information.
The tissue bank has been approved by the Danish Scientific Ethical Committee.
Data
security
The tissue bank database has been developed
with special attention to data security.
Strict procedures regulate access to stored information. These include
user authorization, database user groups with different security levels,
limitation on failed attempts to database access, user records, database
logging, and trained IT-staff and physical measures to increase data security.
Data security and integrity is ensured through back up routines and maintainance
procedures, including server RAID and tape backup.
The tissue bank database has been approved by the Danish Data Protection
Agency.
What is collected
The aim of the colorectal cancer tissue bank is to acquire neoplastic
and control non-neoplastic material from patients with all types of colorectal
neoplasias. By 2010, the colorectal cancer tissue bank holds more than
23,000 samples (adenomas, adenocarinomas, liver metastases, normal mucosa,
and blood) from more than 2,000 patients. Roughly 350 new patients are
added to the bank each year.
In collaboration with the relevant pathological departments the pathological
information associated with the collected tissues is entered into the
database. Manual and automatic procedures ensure that clinical follow
up information for the individual patients is continuously collected and
stored in the database.
Tissue collection
Tissue and blood is collected at the following sites:
Technical staff is permanently present at the Surgical departments to
ensure optimal and immediate handling of the resected tissue. In this
way mRNA expression artifacts due to hypoxia etc. are minimized. When
possible, biopsies are collected from the tumor as well as from the normal
mucosa. Importantly, tumor areas appearing ischemic and/or necrotic are
avoided during the biopsy process. Blood is collected from all patients
entering the tissue bank.
The collected biopsies are labeled with database generated identification
codes and flash frozen in liquid nitrogen within 20 minutes of the resection.
Solid tissue is stored in three different formats: fresh frozen, Tissue
Tek embedded, and embedded in an RNA preserving reagent.
The frozen neoplastic and non-neoplastic tissue is stored in -80°C
freezers at the CMCC freezer facility. Here, special security measures
are taken to avoid thawing and/or exposure to large changes in temperature.
All freezers containing tissue are included in Aarhus University Hospital’'s
secure electricity supply and monitored by a triple layer alarm system.
It is not within the scope of the colorectal cancer tissue bank to store
formalin fixed and paraffin embedded tumor tissue. However, tumor tissue
in this format can be obtained through collaboration with the Pathological
Department THG at Aarhus Hospital.
.
Downstream tissue applications
The flash frozen solid tissue samples are stored as they are. In contrast,
blood samples are processed immediately upon arrival. Half the blood sample
is frozen directly, and from the other half, plasma and DNA is extracted.
Thus, the tissue bank holds readily available blood, plasma, and DNA from
all patients.
Only in relation to specific research projects are DNA, RNA and proteins
isolated from the solid tissue, however when available these molecules
are also registered and stored in the tissue bank.
Quality
Control
All RNA samples are analyzed using the Bioanalyzer from Agilent and the
RNA quality measures such as the 18S/28S ratio and the RNA integrity number
(RIN) are stored with the samples in the database.
Periodic quality controls of the procedures used for collection of tissue
and clinical information and for the associated database are being carried
out with the aim of avoiding possible breakdown
in the system.
These controls specifically monitor:
- Identification and management of samples.
- Suitability of the acquisition and freezing protocols.
- Equipment Maintenance.
- Validation of data.
- Access code control.
|